Abstract
Zolpidem is currently the global market leader in the hypnotic arena. Recently several novel zolpidem formulations have been launched in the U.S. or are in the preregistration development phase. These comprise an extended-release form, two types of sublingual formulations and an oral spray. The pharmacokinetic and pharmacodynamic effects of these formulations are reviewed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
